On Optum services:
Optum Insight’s products and services are sold primarily through a direct sales force.
UNITEDHEALTH GROUP INC (UNH) single-company analysis
This page is a descriptive assembly from a frozen evidence pack of public SEC filing excerpts and verified SEC companyfacts metrics. It is not a rating, recommendation, endorsement, forecast, valuation, or investment advice. Filer viewpoints are attributed to the filer and figures are as of their cited filing dates.
Informational only - not investment advice. See Disclaimer.
Back to UNH company profile. Existing company-page SVG figures remain the source for financial time-series context.
Business & segments
On Optum Health administrative-fee arrangements:
Offerings also include administrative fee arrangements, where Optum Health manages or administers products and services in exchange for a monthly fee, and fee-for-service arrangements, where Optum Health delivers health-related products and medical services for patients at a contracted fee.
On UnitedHealthcare medical access:
As of December 31, 2025, UnitedHealthcare Employer & Individual provides access to medical services for 29.7 million people.
Financial profile
The values below are templated from verified SEC companyfacts-derived facts. The embedded SVG figures show selected annual series from the same facts.
Reported revenue: 447,567,000,000
Operating margin: 4.24%
Free cash flow: 16,075,000,000
Revenue scale is shown from verified SEC companyfacts. Revenue: 447,567,000,000
Operating margin is shown from verified SEC companyfacts. Operating margin: 4.24%
Net margin is shown from verified SEC companyfacts. Net margin: 2.69%
Free cash flow is computed from verified operating cash flow and capital expenditure facts. Free cash flow: 16,075,000,000
Capital expenditures are shown as reported payment magnitude from verified SEC companyfacts. Capital expenditures: 3,622,000,000
Dividends paid are shown as reported cash outflow magnitude from verified SEC companyfacts. Dividends paid: 7,916,000,000
| Metric | Value | Fiscal year | Period end | Source |
|---|---|---|---|---|
| Capital expenditures | 3,622,000,000 | 2025 | 2025-12-31 | USD |
| Dividends paid | 7,916,000,000 | 2025 | 2025-12-31 | USD |
| Free cash flow | 16,075,000,000 | 2025 | 2025-12-31 | USD |
| Liabilities / equity | 2.08 | 2025 | 2025-12-31 | Ratio |
| Net income | 12,056,000,000 | 2025 | 2025-12-31 | USD |
| Net margin | 2.69% | 2025 | 2025-12-31 | Percent |
| Operating cash flow | 19,697,000,000 | 2025 | 2025-12-31 | USD |
| Operating income | 18,964,000,000 | 2025 | 2025-12-31 | USD |
Stated strategy
Key idiosyncratic risks
On customer concentration or dependency:
We depend on the integrity of the data in our information systems to implement new and innovative services, automate and deploy new technologies to simplify administrative processes and clinical decision making, price our products and services adequately, provide effective service to our customers and consumers in an efficient and uninterrupted fashion, provide timely payments to care providers, and accurately report our results of operations.
On competition:
Our businesses face significant competition in all of the markets in which we operate.
Recent developments
On healthcare revenue movement:
Optum Total revenues increased primarily due to growth at Optum Rx, partially offset by Optum Health.
On Optum revenue movement:
Optum Rx Revenues at Optum Rx increased due to higher script volumes from both new clients and growth in existing clients and growth in pharmacy services.